Hartley said gross profit was negatively impacted by $1.9 million in one-time costs in the fourth quarter associated with the BLA approval, two-thirds of which were non-cash stock-based compensation tied to milestone vesting. Excluding one-time items, she attributed margin pressure mainly to higher product costs related to additional testing steps as Avance transitioned to a biologic, partially offset by fewer inventory write-offs and lower shipping costs following the case stock program’s discontinuation.G ...

Principal Financial Group Inc. raised its holdings in AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 69.7% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 51,130 shares of the medical equipment provider’s stock after acquiring an additional 21,002 shares during the quarter. Principal Financial Group Inc. owned approximately 0.11% of AxoGen worth $912,000 as of its most recent filing with the Securities & Exchange Commission. Get AxoGen aler ...